GB202016955D0 - Therapeutic treatments - Google Patents

Therapeutic treatments

Info

Publication number
GB202016955D0
GB202016955D0 GBGB2016955.3A GB202016955A GB202016955D0 GB 202016955 D0 GB202016955 D0 GB 202016955D0 GB 202016955 A GB202016955 A GB 202016955A GB 202016955 D0 GB202016955 D0 GB 202016955D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic treatments
treatments
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2016955.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wista Laboratories Ltd
Original Assignee
Wista Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wista Laboratories Ltd filed Critical Wista Laboratories Ltd
Priority to GBGB2016955.3A priority Critical patent/GB202016955D0/en
Publication of GB202016955D0 publication Critical patent/GB202016955D0/en
Priority to PCT/EP2021/061480 priority patent/WO2021224144A1/en
Priority to US17/997,758 priority patent/US20230165875A1/en
Priority to EP21723699.1A priority patent/EP4146223A1/en
Priority to BR112022022515A priority patent/BR112022022515A2/en
Priority to KR1020227042294A priority patent/KR20230012514A/en
Priority to CN202180043773.6A priority patent/CN116056724A/en
Priority to AU2021267670A priority patent/AU2021267670A1/en
Priority to MX2022013883A priority patent/MX2022013883A/en
Priority to CA3181393A priority patent/CA3181393A1/en
Priority to JP2022567230A priority patent/JP2023525512A/en
Priority to TW110116179A priority patent/TW202200150A/en
Ceased legal-status Critical Current

Links

GBGB2016955.3A 2020-05-05 2020-10-26 Therapeutic treatments Ceased GB202016955D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB2016955.3A GB202016955D0 (en) 2020-10-26 2020-10-26 Therapeutic treatments
JP2022567230A JP2023525512A (en) 2020-05-05 2021-04-30 Methylthioninium compounds used in the treatment of COVID-19
BR112022022515A BR112022022515A2 (en) 2020-05-05 2021-04-30 METHYLTHIONIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19
US17/997,758 US20230165875A1 (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of covid-19
EP21723699.1A EP4146223A1 (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of covid-19
PCT/EP2021/061480 WO2021224144A1 (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of covid-19
KR1020227042294A KR20230012514A (en) 2020-05-05 2021-04-30 treatment method
CN202180043773.6A CN116056724A (en) 2020-05-05 2021-04-30 Methylthioninium compounds for the treatment of covd-19
AU2021267670A AU2021267670A1 (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of COVID-19
MX2022013883A MX2022013883A (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of covid-19.
CA3181393A CA3181393A1 (en) 2020-05-05 2021-04-30 Methylthioninium compounds for use in the treatment of covid-19
TW110116179A TW202200150A (en) 2020-05-05 2021-05-05 Therapeutic treatments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2016955.3A GB202016955D0 (en) 2020-10-26 2020-10-26 Therapeutic treatments

Publications (1)

Publication Number Publication Date
GB202016955D0 true GB202016955D0 (en) 2020-12-09

Family

ID=73727097

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2016955.3A Ceased GB202016955D0 (en) 2020-05-05 2020-10-26 Therapeutic treatments

Country Status (1)

Country Link
GB (1) GB202016955D0 (en)

Similar Documents

Publication Publication Date Title
GB202001980D0 (en) Therapeutic mentods
GB202006960D0 (en) Therapeutic
GB202108303D0 (en) Therapy
GB202111288D0 (en) Combination therapy
GB202004189D0 (en) Combination therapy
GB202016955D0 (en) Therapeutic treatments
GB202006659D0 (en) Therapeutic treatments
GB202117706D0 (en) Therapy
GB202111035D0 (en) Therapy
GB202109893D0 (en) PeptiBAC therapy
GB202104427D0 (en) Therapy
GB202103164D0 (en) Therapy
GB202102211D0 (en) PeptiBAC therapy
GB202019218D0 (en) Therapy
GB202017598D0 (en) Therapy
GB202017554D0 (en) Therapy
GB202110329D0 (en) Therapeutic
GB202015780D0 (en) Therapy
GB202015778D0 (en) Therapy
GB202013834D0 (en) PeptiVAX therapy
GB202013824D0 (en) PeptiBAC therapy
GB202009039D0 (en) Therapy
GB202008031D0 (en) Therapy
GB202004629D0 (en) Therapy
GB202004013D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)